Opzelura

Human medicines European public assessment report (EPAR): Brilique, ticagrelor, Date of authorisation: 03/12/2010, Revision: 23, Status: Authorised

FertiPro N.V. HSA-containing ART media - Procedural steps and scientific information after initial consultation (archive)

FertiPro N.V. HSA-containing ART media - Procedural steps and scientific information after initial consultation

Orphan designation: Expanded human allogeneic mesenchymal adult stem cells extracted from adipose tissue (darvadstrocel) Treatment of anal fistula, 08/10/2009 Withdrawn

Human medicines European public assessment report (EPAR): Regkirona, regdanvimab, Date of authorisation: 12/11/2021, Revision: 9, Status: Withdrawn

Human medicines European public assessment report (EPAR): Vevizye, ciclosporin, Date of authorisation: 19/09/2024, Revision: 3, Status: Authorised

EU Implementation Guide (IG) on veterinary medicines product data in the Union Product Database - Chapter 7: Submission of other post-authorisation data

Report - Industry stakeholders and EU network experts surveys on early engagement fostering innovation

Human medicines European public assessment report (EPAR): Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG), telmisartan, Date of authorisation: 16/12/1998, Revision: 32, Status: Authorised